IL-NIQ
NIQ, the global leader in consumer intelligence, is pleased to announce the NIQ Connect platform capabilities have now expanded to use Snowflake Secure Data Sharing. This capability marks a significant milestone for NIQ's Connect platform, empowering customers in 84 global markets with enhanced data-sharing capabilities and seamless real-time data access. As a result, this can eliminate processing and loading wait times, delivering unparalleled efficiency and agility in a complex consumer landscape.
“By extending their ability to effortlessly access global, omnichannel data, we can empower clients to uncover new pathways to growth even within a very complex consumer landscape,” said Troy Treangen, Chief Product Officer at NIQ. “Innovation is our compass, and our commitment to reengineering the Connect platform has charted a new course. Our strategic investments have allowed us to unlock the power of modern data sharing capabilities, guiding our clients towards a brighter, data-driven future."
NIQ Connect is a crucial asset for enterprises, enabling them to harness their data across all facets of their organization. With integrated data assets, businesses can readily identify emerging trends, pinpoint performance gaps, and respond swiftly to growth opportunities. This global collaboration is poised to unveil novel insights, leading to a deeper understanding of customers' behavior and preferences.
Additional highlights of the NIQ’s Connect platform integration with Snowflake’s Retail Data Cloud include:
- Seamless Data Integration: Companies will benefit from the seamless integration of NIQ's rich consumer and market data into Snowflake’s environment. This integration simplifies access to vast data sources, and drives significant speed improvements for our clients when accessing data.
- Secure Data Sharing: Availability through Snowflake facilitates near real-time data sharing, enabling businesses to access and query NIQ's data instantaneously. This dynamic exchange of information empowers organizations to stay ahead in today's fast-paced business landscape.
- Scalability and Flexibility: NIQ’s Connect platform with Snowflake Secure Data Sharing is designed to scale effortlessly with the growing data needs of businesses. Whether a company is a startup or a Fortune 500 enterprise, this provides the flexibility to adapt and grow in a rapidly changing environment.
- Enhanced AI and Machine Learning Capabilities: Businesses can leverage advanced analytics and machine learning within Snowflake's platform to derive actionable insights from NIQ's data. This synergy fosters innovation, enabling companies to make data-driven decisions with precision.
- Data Security and Compliance: Both NIQ and Snowflake prioritize data security and compliance. The joint solution ensures that sensitive data is protected providing peace of mind to businesses and their customers while enabling them to meet evolving regulatory requirements.
“NIQ is committed to helping companies become more agile at a time when being able to move quickly based on accurate data is paramount,” Treangen added. “This innovative data-sharing approach will provide Connect customers a competitive advantage today and be better prepared for the future. We are modernizing every level of our Connect platform, and we are excited about the enhancements to help our clients thrive.”
“As an incumbent leader in retail and consumer insights, NIQ has been a staple in the retail industry for delivering data that give a competitive edge to retailers and consumer product companies,” said Rosemary DeAragon, Global Head of Retail and Consumer Goods at Snowflake. “We are so excited to bring together the full power of the Snowflake Retail Data Cloud and the NIQ Connect platform, allowing global frictionless access to critical data through Snowflake data sharing.”
NIQ is dedicated to fostering innovation and enabling organizations to thrive in a data-driven world. The collaboration between NIQ and Snowflake represents a transformative step in the world of data sharing and will shape the future of data analytics. As organizations increasingly recognize the value of data in their operations, allowing them to exchange insights seamlessly and efficiently will empower them to unlock new opportunities and navigate the data landscape with ease.
For more information about this NIQ Connect and its benefits, please visit https://nielseniq.com/global/en/solutions/nielseniq-connect/.
About NIQ
NIQ is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. In 2023, NIQ combined with GfK, bringing together the two industry leaders with unparalleled global reach. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full ViewTM.
NIQ, is an Advent International portfolio company with operations in 100+ markets, covering more than 90% of the world’s population. For more information, visit NIQ.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919644465/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
